AstraZeneca PLC (NASDAQ:NASDAQ:AZN) Q3 2022 Earnings Conference Call November 10, 2022 06:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive.
Enhertu, a drug produced by AstraZeneca and Daiichi Sankyo, was found to extend survival by more than six months in patients with a form of advanced breast cancer compared to standard chemotherapy.
By Natalie Grover LONDON (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with a form of adv.